Table 1.
Subject | Gender | Age (year) | Height (cm) | Weight (kg) | Body mass index | Smoking status | Passive smoker | Allergy | Airways affected by allergic reaction | Lung function abnormalities (lung function tests) | AUC(CV > 9.5%) [%] | AUC(CV > 20%) [%] |
---|---|---|---|---|---|---|---|---|---|---|---|---|
S1 | M | 49 | 191 | 82 | 22.5 | Never | No | Yesd | Upperj | Nom | 76 | 29 |
S2 | M | 49 | 185 | 77 | 22.5 | Never | No | Yese | Upperj | No | 77 | 30 |
S3 | M | 50 | 190 | 85 | 23.5 | Never | No | Yesf | Upperj | No | 78 | 30 |
S4 | M | 48 | 187 | 75 | 21.4 | Never | Yesa | No | - | No | 77 | 31 |
S5 | M | 50 | 178 | 72 | 22.7 | Never | No | No | - | No | 78 | 33 |
S6 | M | 69 | 181 | 100 | 30.5 | Never | Yesa | No | - | No | 78 | 34 |
S7 | M | 60 | 188 | 85 | 24.0 | Current | - | No | - | Non | 78 | 34 |
S8 | F | 65 | 177 | 66 | 21.1 | Current | - | Yesg | Lowerk | No | 80 | 34 |
S9 | F | 51 | 170 | 85 | 29.4 | Never | Yesa | No | - | No | 78 | 36 |
S10 | M | 75 | 175 | 92 | 30.0 | Never | No | Yesh | Upperj | Noo | 79 | 39 |
S11 | M | 73 | 175 | 77 | 24.9 | Ex-smoker | - | No | - | No | 80 | 41 |
S12 | F | 67 | 172 | 78 | 26.4 | Never | Yesb | No | - | Nop | 83 | 47 |
S13 | F | 67 | 167 | 79 | 28.3 | Never | Yesc | Yesi | Lowerl | Noq | 84 | 47 |
P1 | M | 55 | 176 | 85 | 27.4 | Never | - | - | - | Yeso,r,s | 83 | 43 |
P2 | M | 81 | 167 | 58 | 20.8 | Ex-smoker | - | - | - | Yes | 90 | 61 |
a20 years during childhood; b14 years during childhood and occupational; c10 years occupational; dgrass, pollen and dust; efur animals and grass; ffur animals and pollen; gstrong fragrances; hcat and chocolate; ibirch pollen, timothy, grass, nuts, penicillin and sulfonamide; jrhinoconjunctivitis; kcough; lshortness of breath; msubject medicated with nasal spray of Budesonide at time of examination; nbased on FEV1, FVC, FEV1/FVC, TLC and RV without bronchodilation; obased on DLCOc before and FEV1, FVC, FEV1/FVC, TLC and RV after bronchodilation; ppossible early signs of emphysema based on a reduced DLCOc value (see Table 2) and an elevated haemoglobin concentration in the blood; qbased on FEV1, FVC and FEV1/FVC without bronchodilation; rsubject medicated with inhalation of Budesonide and Formoterol in combination at time of examination; smoderate obstruction and signs of reversibility.